posted on 2005-02-02, 00:00authored byColin G. Barry, Cynthia S. Day, Ulrich Bierbach
The interactions of [Pt(en)Cl(ACRAMTU-S)](NO3)2 (PT-ACRAMTU, en = ethane-1,2-diamine,
ACRAMTU = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) with adenine in DNA have been studied
using a combination of analytical and high-resolution structural methods. For the first time, a cytotoxic
platinum(II) complex has been demonstrated to form adducts in the minor groove of DNA through platination of the adenine-N3 endocyclic nitrogen. An acidic depurination assay was developed that allowed the
controlled and selective (pH 2, 60 °C, 12 h) release of platinum-modified adenine from drug-treated nucleic acid samples. From the digested mixtures, three adducts were isolated by semipreparative reverse
phase high-performance liquid chromatography and studied by electrospray ionization mass spectrometry (in-line LC−MS), variable-pH 1H NMR spectroscopy, and, where applicable, X-ray crystallography. The three species were identified as the N7 (A*-I), N3 (A*-II), and N1 (A*-III) linkage isomers of
[Pt(en)(ACRAMTU-S)(adenine)]3+ (A*). Incubations carried out with the single- and double-stranded model
sequences, d(TA)5 and d(TA)15, as well as native DNA indicate that the adduct profiles (A*-I:A*-II:A*-III
ratios) are sensitive to the nature of the nucleic acid template. A*-II was found to be a double-strand specific
adduct. The crystal structure of this adduct has been determined, providing ultimate evidence for the N3
connectivity of platinum. A*-II crystallizes in the triclinic space group P1̄ in the form of centrosymmetric
dimers, {[Pt(en)(ACRAMTU-S)(adenine-N3)]2}6+. The cations are stabilized by a combination of adenine−adenine base pairing (N6···N1 2.945(5) Å) and mutual acridine−adenine base stacking. Tandem mass
spectra and 1H chemical shift anomalies indicate that this type of self-association is not merely a crystal
packing effect but persists in solution. The monofunctional platination of adenine at its N7, N3, and N1
positions in a significant fraction of adducts breaks a longstanding paradigm in platinum−DNA chemistry,
the requirement for nucleophilic attack of guanine-N7 as the principal step in cross-link formation. The
biological consequences and potential therapeutic applications of the unique base and groove recognition
of PT-ACRAMTU are discussed.